Coloma Jason V: insider trades.
Coloma Jason V reported 14 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($3.5M), across 1 company.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 13
- Companies
- 1
- Name as filed
- Coloma Jason V
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | Director, Officer · Chief Executive Officer | 14 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-03 | Maze Therapeutics, Inc. | S | 129 | $25.77 | 27,362 | Form 4 |
| 2026-09-03 | Maze Therapeutics, Inc. | S | 11,282 | $26.01 | 27,491 | Form 4 |
| 2026-09-02 | Maze Therapeutics, Inc. | S | 1,375 | $27.12 | 38,773 | Form 4 |
| 2026-09-02 | Maze Therapeutics, Inc. | S | 9,852 | $26.38 | 40,148 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | S | 2,593 | $26.31 | 18,151 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | M | 50,000 | $0 | 50,000 | Form 4 |
| 2026-09-01 | Maze Therapeutics, Inc. | S | 31,908 | $26.29 | 223,355 | Form 4 |
| 2026-08-03 | Maze Therapeutics, Inc. | S | 2,439 | $26.71 | 20,898 | Form 4 |
| 2026-08-03 | Maze Therapeutics, Inc. | S | 154 | $27.09 | 20,744 | Form 4 |
| 2026-08-03 | Maze Therapeutics, Inc. | S | 30,304 | $26.71 | 256,867 | Form 4 |
| 2026-08-03 | Maze Therapeutics, Inc. | S | 1,604 | $27.09 | 255,263 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | S | 1,597 | $30.44 | 287,171 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | S | 2,593 | $29.98 | 23,337 | Form 4 |
| 2026-07-01 | Maze Therapeutics, Inc. | S | 30,311 | $29.95 | 288,768 | Form 4 |
Questions
What stock did Coloma Jason V buy or sell?
Coloma Jason V reported 14 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 13 sales ($3.5M), across 1 company.
Is Coloma Jason V the same person as other filers with this name?
This page covers SEC CIK 1676170 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/coloma-jason-v-1676170.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.